[1]Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency. [2]Editorial: Community series in novel insights into immunotherapy targeting tumor microenvironment in ovarian cancer: volume I [3]Immunostimulatory gene therapy combined with checkpoint blockade reshapes tumor microenvironment and enhances ovarian cancer immunotherapy [4]The nexus of dynamic T cell states and immune checkpoint blockade therapy in the periphery and tumor microenvironment [5]Establishment of a tumor immune microenvironment-based molecular classification system of breast cancer for immunotherapy. [6]Tumor immune microenvironment-modulated nanostrategy for the treatment of lung cancer metastasis [7]Prediction of immunotherapy response of bladder cancer with a pyroptosis-related signature indicating tumor immune microenvironment [8]AGRN-Positive Tumor Cells Promoting Immunotherapy Resistance in Lung Adenocarcinoma by Reshaping the Immune Microenvironment [9]Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation [10]BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma